| The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria International Team for the Revision of the International Criteria for Behçet ... Journal of the european Academy of Dermatology and Venereology 28 (3), 338-347, 2014 | 958 | 2014 |
| Dapsone in Behçet's disease: a double‐blind, placebo‐controlled, cross‐over study KE Sharquie, RA Najim, AR Abu‐Raghif The Journal of dermatology 29 (5), 267-279, 2002 | 205 | 2002 |
| Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo‐controlled clinical trial FT Al‐Gurairi, M Al‐Waiz, KE Sharquie British Journal of Dermatology 146 (3), 423-431, 2002 | 199 | 2002 |
| Prevalence and patterns of neurological involvement in Behçet’s disease: a prospective study from Iraq A Al-Araji, K Sharquie, Z Al-Rawi Journal of Neurology, Neurosurgery & Psychiatry 74 (5), 608-613, 2003 | 187 | 2003 |
| Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis KE Sharquie, RA Najim, IB Farjou, DJ Al‐Timimi Clinical and experimental dermatology 26 (1), 21-26, 2001 | 145 | 2001 |
| Onion juice (Allium cepa L.), a new topical treatment for alopecia areata KE Sharquie, HK Al‐Obaidi The Journal of dermatology 29 (6), 343-346, 2002 | 143 | 2002 |
| Lactic acid as a new therapeutic peeling agent in melasma KE Sharquie, MM Al‐Tikreety, SA Al‐Mashhadani Dermatologic surgery 31 (2), 149-154, 2005 | 135 | 2005 |
| Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels KE Sharquie, MM Al-Tikreety, SA Al-Mashhadani Dermatologic surgery 32 (12), 1429-1436, 2006 | 104 | 2006 |
| Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony KE Sharquie, KK Al‐Talib, AC Chu British Journal of Dermatology 119 (1), 53-57, 1988 | 100 | 1988 |
| Behçet's disease in Iraqi patients. ZS Al-Rawi, KE Sharquie, SJ Khalifa, FM Al-Hadithi, JJ Munir Annals of the rheumatic diseases 45 (12), 987-990, 1986 | 86 | 1986 |
| Topical zinc sulphate solution for treatment of viral warts. KE Sharquie, AA Khorsheed, AA Al-Nuaimy Saudi Medical Journal 28 (9), 1418-1421, 2007 | 85 | 2007 |
| A comparative controlled trial of intralesionally‐administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis KE Sharquie, RA Najim, IB Farjou Clinical and Experimental Dermatology 22 (4), 169-173, 1997 | 84 | 1997 |
| Suppression of Behçe? s disease with dapsone KE Sharquie British Journal of Dermatology 110 (4), 493-494, 1984 | 84 | 1984 |
| Oral zinc sulfate in the treatment of rosacea: a double‐blind, placebo‐controlled study KE Sharquie, RA Najim, HN Al‐Salman International journal of dermatology 45 (7), 857-861, 2006 | 80 | 2006 |
| COVID-19 infection is a major cause of acute telogen effluvium KE Sharquie, RI Jabbar Irish Journal of Medical Science (1971-) 191 (4), 1677-1681, 2022 | 76 | 2022 |
| Inflammatory changes in vitiligo: stage I and II depigmentation KE Sharquie, SH Mehenna, AA Naji, H Al-Azzawi The American journal of dermatopathology 26 (2), 108-112, 2004 | 75 | 2004 |
| Bacille Calmette-Guerin immunotherapy of viral warts. KE Sharquie, JR Al-Rawi, AA Al-Nuaimy, SH Radhy Saudi medical journal 29 (4), 589-593, 2008 | 74 | 2008 |
| The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone. KE Sharquie, RA Najim, RK Al-Hayani, AA Al-Nuaimy, DM Maroof Saudi medical journal 29 (5), 734-738, 2008 | 73 | 2008 |
| Oral zinc sulfate in the treatment of Behcet's disease: A double blind cross‐over study KE Sharquie, RA Najim, WS AL‐DORI, RK AL‐HAYANI The Journal of dermatology 33 (8), 541-546, 2006 | 69 | 2006 |
| Zinc sulphate in the treatment of cutaneous leishmaniasis: an in vitro and animal study RA Najim, KE Sharquie, IB Farjou Memórias do Instituto Oswaldo Cruz 93, 831-837, 1998 | 63 | 1998 |
